Consolidation and updates to the Executive Order on Euphoriant Drugs (BEK nr 405 af 26/03/2026, Bekendtgørelse om euforiserende stoffer)
Danish authoritoes have consolidated the Executive Order on Euphoriant Drugs (BEK nr 405 af 26/03/2026, Bekendtgørelse om euforiserende stoffer), bringing several years worth of updates into one piece of legislation. At the same time it has added 61 new substances as list B scheduled substances, given below:-
About the author
Joe Bradley is a Biochemist with decades of experience in controlled drug regulations, drug discovery and cheminformatics. He has spent the last 12 years working to improve controlled drug and regulatory compliance within the chemicals and pharmaceuticals industry, through the development of software solutions which allows the rapid and accurate identification of controlled and regulated chemicals.
He founded Scitegrity in 2011 and the tools he helped create are now used by many of the worlds top chemical and pharmaceutical companies, specialist controlled drug suppliers and regulators.
He has consulted for regulators globally, helping to refine and assess the impact of proposed controlled drug regulations before final enactment.
When not absorbed in chemical regulations you'll find him on is skateboard, trials bike or with snooker cue in hand.
- 1. 5,3-AB-CHMFUPPYCA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide)
- 12. ADB-B-5Br-INACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1-butyl-1H-indazole-3-carboxamide)
- 16. ADB-D-5Br-INACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1-decyl-1H-indazole-3-carboxamide)
- 17. 3,5-ADB-4en-PFUPPYCA (N-(1-carbamoyl-2,2-dimethyl-propyl)-5-(4-fluorophenyl)-2-pent-4-enyl-pyrazole-3-carboxamide)
- 18. ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide)
- 19. ADB-FUBIACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-acetamide)
- 21. ADB-HEXINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide)
- 23. ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)
- 25. ADMB-INACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-indazole-3-carboxamide)
- 24. ADMB-5en-HEXINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(hex-5en-1-yl)-1H-indazole-3-carboxamide)
- 26. ADMB-3TMS-PRINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(3-(trimethylsilyl)propyl)-1H-indazole-3-carboxamide)
- 27. A-FUBIACA (N-(1-adamantyl)-2-[1-[(4-fluorophenyl)methyl]indol-3-yl]acetamide)
- 29. AKB-57 (1-adamantyl 1-pentylindazole-3-carboxylate)
- 46. AMB-CHMICA (methyl 2-((1-(cyclohexylmethyl)-1H-indol-3-yl)formamido)-3-methylbutanoate)
- 47. AMB-4en-PICA (methyl 3-methyl-2-[1-(pent-4-en-1-yl)-1H-indole-3-carboxamido]butanoate)
- 51. AM-6527 5-fluoropentyl derivative (1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide)
- 57. A-PBITMO (adamantan-1-yl(3-pentyl-2-thioxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methanone)
- 59. A-PONASA (N-(adamantan-1-yl)-4-(pentyloxy)naphthalene-1-sulfonamide)
- 60. BB-22 (8-quinolinyl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate)
- 90. CH-BINACA (1-butyl-N-cyclohexyl-1H-indazole-3-carboxamide)
- 91. CH-FUBBMPDORA (N-{5-bromo-1-[(4-fluorophenyl)methyl]-4-methyl-2-oxo-1,2-dihydropyridin-3-yl}cyclohexanecarboxamide)
- 92. CH-FUBIACA (N-cyclohexyl-2-(1-(4-fluorobenzyl)-1H-indol-3-yl)acetamide)
- 95. CHM-MDA-19 (N-[(Z)-[1-(cyclohexylmethyl)-2-oxo-indolin-3-ylidene]amino]benzamide)
- 98. 5Cl-MDMB-PINACA (methyl 2-(1-(5-chloropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
- 114. CUMYL-CBMICA (1-(Cyclobutylmethyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide)
- 116. CUMYL-EINACA (1-Ethyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide)
- 119. CUMYL-FUBINACA (1-[(4-fluorophenyl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide)
- 120. CUMYL-INACA ((N-(2-Phenylpropan-2-yl)-1H-indazole-3-carboxamide)
- 121. CUMYL-NBMINACA (1-(bicyclo[2.2.1]heptan-2-ylmethyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide)
- 123. CUMYL-PINACA (1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide)
- 124. CUMYL-PMINACA (1-pentyl-N-(2-phenylpropan-2-yl)-4,5,6,7-tetrahydro-1H-4,7-methanoindazole-3-carboxamide)
- 125. CUMYL-3TMS-PRINACA (N-(2-phenylpropan-2-yl)-1-(3-(trimethylsilyl)propyl)-1H-indazole-3-carboxamide)
- 160. EDMB-4en-PINACA (ethyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazol-3-carbonyl]amino}butanoate)
- 163. 4ene-PDMB-4ene-PINACA (pent-4-en-1-yl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)-butanoate)
- 182. 4F-ABINACA (N-(adamantan-1-yl)-1-(4-fluorobutyl)-1H-indazole-3-carboxamide)
- 184. 5F-ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide)
- 185. 4F-ADMB-BINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobutyl)-1H-indazole-3-carboxamide)
- 191. 5F-EDMB-PINACA (ethyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate)
- 207. 5F-MDMB-P7AICA (methyl 2-{[1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]formamido}-3,3-dimethylbutanoate)
- 209. 4F-MDMB-PINACA (methyl 2-[1-(4-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate)
- 213. 5F-SDB-005 (naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate)
- 214. FUB-NPB-22 (8-quinolyl 1-[(4-fluorophenyl)methyl]indazole-3-carboxylate)
- 226. HU-331 (3-hydroxy-2-(6-isopropenyl-3-methyl-cyclohex-2-en-1-yl)-5-pentyl-1,4-benzoquinone)
- 257. JWH-018 indazole analog (naphthalen-1-yl(1-pentyl-1H-indazol-3-yl)methanone)
- 271. MADMB-4en-PINACA (N-(3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide)
- 274. MDA-19 4ene-pentyl analogue (N-[(Z)-(2-oxo-1-pent-4-enyl-indolin-3-ylidene)amino]benzamide)
- 276. MDA-19 pentyl analogue (N-[(Z)-(2-oxo-1-pentyl-indolin-3-ylidene)amino]benzamide)
- 278. MDMB-BINACA (methyl 2-(1-butyl-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
- 279. MDMB-5Br-INACA (methyl 2-(5-Bromo-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
- 280. MDMB-7Br-INACA (methyl 2-(7-bromo-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
- 283. MDMB-CHMINACA (methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
- 284. MDMB-5en-HEXINACA (methyl 2-(1-(hex-5-en-1-yl)-1H-indazol-3-carboxamido)-3,3-dimethylbutanoate)
- 285. MDMB-4en-P-5Br-INACA (methyl 2-{[5-bromo-1-(pent-4-en-1-yl)-1H-indazol-3-carbonyl]amino}-3,3-dimethylbutanoate)
- 287. MDMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
- 288. MDMB-INACA (methyl 2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
- 289. MDMB-PINACA (methyl 3,3-dimethyl-2-(1-pentyl-1H-indazole-3-carboxamido)butanoate)
- 335. MMB-PINACA (methyl 3-methyl-2-[(1-pentyl-1H-indazole-3-carbonyl)amino]butanoate)
- 343. MPhP-2201 (methyl 2 ‐ (1 ‐ (5 ‐ fluoropentyl) ‐ 1H ‐ indole‐3‐carboxamido) ‐ 3 ‐ phenylpropanoate)
- 360. NMDMSB (1-naphthyl 4-methyl-3-(dimethylsulfamoyl)-benzoate)
- 420. SDB-005 (naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate)
- 447. URB-597 (3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate)
Do you want to be able to easily and automatically check if your chemicals are controlled and regulated around the world - even for novel and propriatory chemicals - then you need Controlled Substances Squared.
Trusted by our Clients